AUSTIN, Texas, July 31, 2018 -- Aerin Medical, Inc. ("Aerin") announced that over 1,000 patients suffering from nasal obstruction have successfully received the VIVAER® Nasal Airway Remodeling treatment ("VIVAER") which uses patented non-invasive low temperature radio frequenc...

Workbar, Boston’s coworking space trailblazer, has announced plans to open a 20,500 square foot workspace located immediately off Route 95 on Summit Drive in Burlington, MA. Slated to open early December 2018, the new workspace will serve as Workbar’s 9th location in Massachus...

Southborough, MA (July 24, 2018) – Beals and Thomas, Inc. (B+T), a multi-disciplinary land use planning, design, and permitting consulting firm, has expanded to Boston with its third office at 295 Devonshire Street. The new downtown location will support the firm’s growing ope...

Boston, MA -- March 15, 2018 -- Reportable Inc., has launched a paid beta following the success of multiple case studies validating the Company's modern news release and distribution model. A recent head to head comparison of the same release issued on both a traditional wire ...

Southborough, MA (July 2018) – Jeff Heidelberg PE, LEED AP has joined Beals and Thomas, Inc. (B+T) as the Manager of Urban Development Services. He is responsible for managing resources, project teams and schedules to address the design and permitting acquisition of complex la...

New York, NY, July 20, 2018 -- The healthy cooking with extra virgin olive oil trend is as hot as a summer grill. But, it can be confusing trying to decide among all of the EVOO choices on your supermarket shelf.  Despite what you may think, good quality extra virgin olive oil...

New York City - July 19, 2018 - Ekin, the leader in safe city technologies, today launched Ekin Spotter, a compact smart city device that provides traffic management, environmental analysis and surveillance. Available in the United States starting today, Ekin Spotter is the fi...

TORRANCE, Calif. – July 18, 2018 – Emmaus Life Sciences, Inc. (Emmaus) announced today that the New England Journal of Medicine (NEJM) has published the results of its 48-week phase 3 clinical trial of Endari™ (L-glutamine oral powder) which supported the FDA approval in July ...

LEXINGTON, Mass., July 17, 2018 -- Pulmatrix, Inc. (PULM) announced today that all dosing and follow up visits have been completed for Part 3 of the ongoing first-in-human study of Pulmazole (PUR1900) - an inhaled iSPERSETM formulation of the anti-fungal drug itraconazole for ...

Los Angeles, CA, August 10, 2018 -- The global non-profit organization The Keep A Breast Foundation will launch the 3rd annual national campaign, Fit 4 Prevention, to raise $1 million for breast cancer prevention. Fit 4 Prevention raises awareness about cancer prevention thro...